Medifast (MEX:MED) Cyclically Adjusted PB Ratio: (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MED Medifast Inc MEX:MED
63 GF Score
Price MXN180.00
GF Value MXN156.53
! 2 Warning Signs
View Full Analysis

What is Medifast Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medifast  (MEX:MED) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Medifast Cyclically Adjusted PB Ratio Related Terms


Medifast Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Medifast's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medifast Cyclically Adjusted PB Ratio Chart

Medifast Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.60 9.96 5.29 1.26 0.70

Medifast Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 0.90 0.70 0.65 0.00

MEX:MED vs RGS, CLIK, EVTK: Cyclically Adjusted PB Ratio Comparison

For the Personal Services subindustry, Medifast's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast Cyclically Adjusted PB Ratio vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medifast's Cyclically Adjusted PB Ratio falls into.


MEX:MED
63GF Score
Medifast Inc MEX:MED
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medifast Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Medifast's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Medifast's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=306.465/333.9520*333.9520
=306.465

Current CPI (Jun. 2026) = 333.9520.

Medifast Quarterly Data

Book Value per Share CPI Adj_Book
201609 154.921 241.428 214.292
201612 166.756 241.432 230.659
201703 156.555 243.801 214.445
201706 157.843 244.955 215.190
201709 164.610 246.819 222.721
201712 178.137 246.524 241.312
201803 171.134 249.554 229.011
201806 169.125 251.989 224.135
201809 174.661 252.439 231.059
201812 180.510 251.233 239.943
201903 199.015 254.202 261.451
201906 204.077 256.143 266.070
201909 189.055 256.759 245.893
201912 168.066 256.974 218.411
202003 220.426 258.115 285.190
202006 229.203 257.797 296.911
202009 262.836 260.280 337.231
202012 265.710 260.474 340.665
202103 303.915 264.877 383.170
202106 330.362 271.696 406.061
202109 347.371 274.310 422.898
202112 358.281 278.802 429.153
202203 372.338 287.504 432.491
202206 236.413 296.311 266.445
202209 277.064 296.808 311.737
202212 278.004 296.797 312.806
202303 282.950 301.836 313.056
202306 292.152 305.109 319.770
202309 308.709 307.789 334.950
202312 313.876 306.746 341.714
202403 320.121 312.332 342.280
202406 343.861 314.175 365.507
202409 373.286 315.301 395.367
202412 400.619 315.605 423.908
202503 392.670 319.799 410.048
202506 370.048 322.561 383.116
202509 358.349 324.800 368.446
202512 325.875 324.054 335.829
202603 320.597 330.213 324.227
202606 306.465 333.952 306.465

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Medifast (MEX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of MXN180.00 is trading 15% above its estimated GF Value™ of MXN156.53.

Key valuation signals for MEX:MED:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: MXN156.53 vs. price of MXN180.00 (15% above fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the MEX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medifast Business Description

Other Exchanges MED:USA0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
63GF Score

Get the complete analysis for MEX:MED

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN180.00
Price
MXN156.53
GF Value